USPTO Initiatives lead to the Quickest Issuance of First Actions Since 2002
Each year, the United States Patent and Trademark Office (“USPTO”) publishes a comprehensive document detailing statistics, achievements, and future goals…
Each year, the United States Patent and Trademark Office (“USPTO”) publishes a comprehensive document detailing statistics, achievements, and future goals…
On January 7, 2020, in Amgen Inc. v. Amneal Pharmaceuticals, the CAFC decided that the open ended term “comprising” controlled,…
The holiday season is upon us! As our part of the hemisphere gets colder, we prepare ourselves for the festive…
The USPTO examiners use the broadest reasonable interpretation (BRI) when construing claims during examination of patent applications. The BRI standard…
Open Enrollment Choices? With open enrollment happening right now or very soon for most United States-based companies, it is worth…
The United States Court of Appeals for the Federal Circuit (“CAFC” or “Federal Circuit”) recently issued two precedential decisions on…